No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1742 |
4. Check minimum number of eventsNone |
1742 |
5. Include endpointsNone |
1742 |
6. Filter based on genotype QC (FinnGen only) |
1742 |
Control definitions (FinnGen only)
- Control exclude
- AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Scabies
based on the number of shared cases.
Similar with more cases:
- Pediculosis, acariasis and other infestations
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 18964 | 6637 | 12241 |
| Only index persons | 16643 | 5825 | 10818 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | 0.19 | 0.34 |
| Only index persons | 0.34 | 0.21 | 0.41 |
| Median age at first event (years) | |||
| Whole population | 20.91 | 21.44 | 20.50 |
| Only index persons | 21.13 | 22.22 | 20.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1742 | 767 | 975 |
| Unadjusted period prevalence (%) | 0.36 | 0.26 | 0.43 |
| Median age at first event (years) | 25.24 | 29.95 | 21.54 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1509
- Matched controls
- 15088
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
13300
ICD-8 Finland
NA
+∞
323.0
456
*
B86
ICD-10 Finland
Scabies
272.9
323.0
925
87
1330A
ICD-9 Finland
Acariasis, Scabies
+∞
139.8
132
*
L29.9
ICD-10 Finland
Pruritus, unspecified
12.1
61.5
115
102
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
53.4
352
1362
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.2
46.6
279
1000
D07AC01
ATC
betamethasone; topical
2.1
35.7
525
3028
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.8
31.9
232
927
D07AB08
ATC
desonide; topical
2.8
27.3
190
736
E0000UV
ATC
NA
1.9
26.5
586
3842
D07AC13
ATC
mometasone; topical
2.0
26.1
429
2521
S02
ICPC
Pruritus
4.7
25.0
87
193
L29
ICD-10 Finland
Pruritus
10.3
23.4
46
46
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
22.7
406
2442
J01DB01
ATC
cefalexin; oral
1.8
20.8
1211
10386
R06AE07
ATC
cetirizine; oral
1.7
20.2
649
4666
S72
ICPC
Scabies/other acariasis
9.3
19.9
41
45
L29.8
ICD-10 Finland
Other pruritus
8.6
19.5
42
50
N02AX02
ATC
tramadol; systemic, rectal
1.7
18.8
565
3959
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
18.5
132
518
N06AB04
ATC
citalopram; systemic
1.9
18.4
303
1749
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
18.4
547
3814
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
18.3
545
3801
L30.3
ICD-10 Finland
Infective dermatitis
4.2
18.0
69
170
H02AB06
ATC
prednisolone; systemic
1.6
17.6
614
4460
N06AX11
ATC
mirtazapine; oral
1.7
17.5
426
2794
N05AH04
ATC
quetiapine; oral
1.9
17.5
281
1607
M54.5
ICD-10 Finland
Low back pain
1.7
17.2
457
3076
A02BC02
ATC
pantoprazole; systemic
1.6
17.1
836
6608
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
17.0
552
3923
L50.3
ICD-10 Finland
Dermatographic urticaria
6.4
16.7
44
71
N05BA01
ATC
diazepam; systemic, rectal
2.2
16.7
191
950
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
16.6
290
1704
N05CF01
ATC
zopiclone; oral
1.7
16.5
391
2537
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
15.4
171
841
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
15.3
598
4429
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
15.2
130
561
TQW80
NOMESCO Finland
Local dermatologic skincare
4.7
15.0
51
112
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
14.8
371
2438
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
14.7
205
1107
N05BA04
ATC
oxazepam; oral
1.7
14.3
317
2001
L03
ICPC
Low back symptom/complaint
1.7
14.2
322
2046
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
14.2
1049
8955
D07AD01
ATC
clobetasol; topical
2.0
14.1
204
1116
M79.6
ICD-10 Finland
Pain in limb
1.6
14.0
451
3162
N03AX16
ATC
pregabalin; oral
1.7
13.7
304
1921
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
13.6
100
399
D07BC01
ATC
betamethasone and antiseptics; topical
2.1
13.5
169
874
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
13.4
129
591
N07BA03
ATC
varenicline; oral
2.6
13.4
98
391
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
5.8
13.3
37
65
SPAT1260
SPAT
Consultation of another employee
1.8
13.1
235
1384
SPAT1310
SPAT
Counselling related to known health issue
1.6
12.9
440
3118
S29
ICPC
Skin symptom/complaint other
1.9
12.8
219
1268
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.1
12.8
69
227
N06AX16
ATC
venlafaxine; oral
1.9
12.7
206
1174
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.7
470
3395
XQ843
NOMESCO Finland
Examination of infestation with microscope
+∞
12.5
12
*
C03CA01
ATC
furosemide; systemic
1.8
12.5
243
1468
L17
ICPC
Foot/toe symptom/complaint
1.7
12.5
313
2042
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
12.4
238
1433
SPAT1263
SPAT
Sampling
1.5
12.4
569
4314
N02BE01
ATC
paracetamol; systemic, rectal
1.6
12.0
1162
10306
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
11.8
216
1279
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
11.7
699
5586
R51.80
ICD-10 Finland
Headache
1.8
11.7
216
1282
S18
ICPC
Laceration/cut
1.5
11.6
506
3782
AA1AD
NOMESCO Finland
CT of head and brain
1.7
11.5
267
1701
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
11.5
612
4769
N05AX08
ATC
risperidone; systemic
2.3
11.5
109
498
D02AE01
ATC
carbamide; topical
2.4
11.2
97
423
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
11.1
779
6398
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
11.1
130
652
N03AX12
ATC
gabapentin; oral
1.8
11.1
189
1093
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
11.1
160
873
N05AA02
ATC
levomepromazine; systemic
2.7
11.1
77
299
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.1
841
7020
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
11.0
289
1902
J20
ICD-10 Finland
Acute bronchitis
2.1
11.0
127
636
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
10.9
651
5174
D07AA02
ATC
hydrocortisone; topical
1.8
10.9
201
1194
WX110
NOMESCO Finland
Local anesthesy
1.5
10.8
987
8516
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
4.3
10.8
39
93
XQ845
NOMESCO Finland
Dermatoscopy
7.2
10.8
25
35
L28.2
ICD-10 Finland
Other prurigo
17.9
10.7
16
9
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.6
10.5
35
77
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
10.5
170
964
R74
ICPC
Upper respiratory infection acute
1.5
10.5
428
3137
R06.0
ICD-10 Finland
Dyspnoea
1.6
10.4
265
1729
WX290
NOMESCO Finland
Other blockade of nerve
1.4
10.4
685
5536
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
10.3
308
2094
R06AX27
ATC
desloratadine; oral
1.5
10.3
378
2701
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
10.3
149
814
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
10.3
266
1742
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
10.2
182
1070
SPAT1240
SPAT
Therapeutic discussion
1.8
10.2
175
1016
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.5
10.0
75
306
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.7
9.6
41
114
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
9.6
111
555
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
9.6
231
1481
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
9.6
949
8212
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
9.6
152
858
N06AX21
ATC
duloxetine; oral
1.9
9.6
146
810
R60.0
ICD-10 Finland
Localized oedema
2.0
9.5
116
592
M03BX02
ATC
tizanidine; oral
1.4
9.5
833
7050
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.1
9.4
104
510
SPAT1312
SPAT
General health counselling
1.5
9.2
431
3233
SPAT1254
SPAT
Administration of medicine
1.7
9.1
195
1208
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
9.1
95
454
S21
ICPC
Skin texture symptom/complaint
1.8
9.0
151
869
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
9.0
351
2530
J01FF01
ATC
clindamycin; systemic
1.5
9.0
347
2500
L20.0
ICD-10 Finland
Besnier prurigo
2.0
8.9
116
609
N05AH03
ATC
olanzapine; systemic
2.1
8.9
105
531
E000001
ATC
NA
1.6
8.8
272
1862
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
8.6
87
411
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.6
325
2328
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.5
820
6993
SPAT1234
SPAT
Support of social functional capacity
2.7
8.4
57
219
M79.1
ICD-10 Finland
Myalgia
1.8
8.4
154
913
P15
ICPC
Chronic alcohol abuse
2.7
8.3
54
204
M01AH05
ATC
etoricoxib; oral
1.4
8.3
758
6394
SPAT1283
SPAT
Restricted health certificate
1.5
8.3
300
2125
N02AA05
ATC
oxycodone; systemic
1.8
8.2
137
784
P03
ICPC
Feeling depressed
1.8
8.2
149
879
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.9
8.1
116
631
L12
ICPC
Hand/finger symptom/complaint
1.7
8.1
186
1177
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.3
8.1
74
334
M01AE02
ATC
naproxen; oral, rectal
1.4
8.1
774
6565
S06.0
ICD-10 Finland
Concussion
1.8
8.1
141
821
M25.5
ICD-10 Finland
Pain in joint
1.5
8.0
346
2541
EBA00
NOMESCO Finland
Extraction of tooth
1.4
8.0
460
3575
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
8.0
431
3311
N07BB01
ATC
disulfiram; oral
2.2
8.0
78
363
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.1
8.0
41
134
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.7
7.9
51
191
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
3.7
7.9
32
87
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
7.9
139
813
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
7.8
146
871
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.4
7.8
64
276
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
7.7
174
1093
N06AA09
ATC
amitriptyline; systemic
1.9
7.7
105
562
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.7
443
3438
S97
ICPC
Chronic ulcer skin
2.5
7.7
58
239
L08
ICPC
Shoulder symptom/complaint
1.6
7.7
206
1358
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
7.7
106
569
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
7.6
262
1833
XQ848
NOMESCO Finland
Dermatological photography
3.3
7.6
36
111
J01MA12
ATC
levofloxacin; systemic
1.6
7.6
199
1306
N03AE01
ATC
clonazepam; systemic
2.1
7.6
80
385
WZC30
NOMESCO Finland
Teaching
1.7
7.5
156
959
N06AB06
ATC
sertraline; oral
1.7
7.5
146
879
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
7.4
179
1149
R06AE09
ATC
levocetirizine; oral
1.6
7.4
192
1255
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
7.3
113
630
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.3
202
1340
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.3
864
7524
R03AC02
ATC
salbutamol; inhalant
1.3
7.3
680
5709
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
7.3
465
3669
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
7.3
335
2488
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
7.2
318
2341
H02AB04
ATC
methylprednisolone; systemic
1.7
7.2
163
1026
SPAT1211
SPAT
Application of soft bandage
1.8
7.2
116
660
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
7.2
128
754
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
7.0
309
2272
R05
ICPC
Cough
1.5
7.0
271
1942
SPAT1153
SPAT
Removal of sutures
1.4
7.0
343
2577
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
7.0
76
373
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
5.9
6.9
18
31
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.9
1290
12069
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.4
6.9
53
222
D11
ICPC
Diarrhoea
1.7
6.9
155
975
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
6.9
96
518
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
6.9
298
2184
SPAT1301
SPAT
No procedures
1.4
6.8
368
2813
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.8
226
1571
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
3.1
6.8
35
116
N76.0
ICD-10 Finland
Acute vaginitis
2.1
6.7
76
379
T90
ICPC
Diabetes non-insulin dependent
1.5
6.7
232
1626
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.7
485
3901
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.9
6.6
38
133
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
6.6
706
6020
N03AX09
ATC
lamotrigine; oral
2.1
6.6
75
374
A02BC01
ATC
omeprazole; systemic
1.4
6.6
303
2246
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.6
457
3649
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
6.6
101
565
N05AX12
ATC
aripiprazole; systemic
2.1
6.5
66
317
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
6.5
118
697
E000002
ATC
NA
1.6
6.4
155
993
S10
ICPC
Boil/carbuncle
2.1
6.4
70
346
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.9
6.4
35
121
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.1
6.4
65
311
C07AA05
ATC
propranolol; systemic
1.5
6.4
235
1666
SPAT1216
SPAT
Assessment of functional ability
1.7
6.3
134
830
SPAT1229
SPAT
Assessment of need for aid
2.1
6.3
71
352
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
6.3
514
4197
A10BA02
ATC
metformin; oral
1.4
6.3
282
2080
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
6.3
132
815
N06AA06
ATC
trimipramine; systemic
3.0
6.3
33
111
K05.31
ICD-10 Finland
Periodontitis pronounced
1.8
6.3
106
613
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.8
6.2
19
40
C07AB07
ATC
bisoprolol; oral
1.4
6.2
460
3699
M54
ICD-10 Finland
Dorsalgia
1.7
6.2
139
874
R21
ICPC
Throat symptom/complaint
1.4
6.2
289
2150
M48.0
ICD-10 Finland
Spinal stenosis
1.8
6.2
105
609
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
6.1
256
1860
Z01.2
ICD-10 Finland
Dental examination
1.3
6.1
551
4565
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.1
196
1348
UJF32
NOMESCO Finland
Coloscopy
1.4
6.1
262
1918
L28
ICPC
Limited function/disability (L)
1.6
6.1
136
856
P76
ICPC
Depressive disorder
1.8
6.1
95
535
F32.1
ICD-10 Finland
Moderate depressive episode
1.9
6.1
84
456
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
10.1
6.0
11
11
N03AG01
ATC
valproic acid; systemic, rectal
1.9
6.0
89
492
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
6.0
107
628
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
67
8.76
44.87
1.4
1.3
22.3
18.0
u/ml
—
10
13
44
59
7.62
31.05
1.5
1.2
92.0
71.3
titre
—
5
8
906
6606
1.77
29.66
7.4
6.2
10.3
11.8
umol/l
4.49
855
6268
600
4050
1.73
24.43
3.4
2.6
57.8
57.0
u/l
0.14
542
3782
1208
9857
1.74
23.94
4.8
3.8
11.5
10.0
mm/h
2.93
1110
9206
1013
7893
1.68
23.79
10.9
9.0
4.3
4.0
e9/l
3.23
898
6953
1066
8467
1.67
22.78
5.0
3.8
175.9
1352.0
e6/l
1.06
17
116
720
5196
1.66
22.30
6.2
5.1
35.3
36.4
g/l
4.87
669
4879
978
7653
1.63
21.69
7.0
4.8
6.7
6.6
mmol/l
0.58
920
7094
726
5300
1.63
21.16
9.1
6.3
1.2
1.2
mmol/l
0.74
668
4833
1215
10088
1.68
20.88
9.3
7.2
78.8
77.2
u/l
0.53
1163
9548
320
1911
1.83
19.21
2.3
1.9
—
—
—
0
0
776
5857
1.59
19.08
8.4
6.9
1.2
1.2
mmol/l
0.92
634
4979
172
850
2.14
17.82
4.1
3.9
5.1
5.1
kpa
0.00
162
795
279
1633
1.84
17.77
7.8
6.7
1.1
1.0
mmol/l
1.74
263
1539
633
4614
1.58
17.71
4.6
3.2
132.1
41.6
ng/l
0.44
416
2857
164
807
2.14
17.17
3.9
4.0
1.3
1.5
mmol/l
0.27
123
592
323
2018
1.74
16.41
4.4
3.9
0.8
0.8
mmol/l
0.96
305
1923
514
3675
1.57
15.14
2.5
2.1
298.1
280.2
u/l
0.10
489
3482
353
2316
1.66
14.81
3.1
2.1
—
—
—
0
0
434
3017
1.58
14.32
2.5
2.1
3.0
2.8
mg/l
0.66
360
2600
350
2310
1.64
14.29
2.0
1.9
1.5
1.5
%
1.03
314
2085
1548
14170
1.83
14.06
19.4
12.1
22.2
22.5
mg/l
0.12
1275
10968
420
2912
1.58
13.96
3.8
3.0
1465.9
1040.2
ng/l
1.35
333
2439
229
1355
1.79
13.90
21.5
18.2
1.4
1.2
inr
1.13
48
207
178
974
1.92
13.84
1.6
1.3
368.5
244.2
u/ml
0.37
162
909
214
1245
1.82
13.73
4.3
3.1
—
—
—
0
0
492
3554
1.54
13.58
4.3
3.5
0.0
0.0
estimate
1.08
188
1268
1177
10130
1.50
13.49
4.1
3.1
53.2
47.1
u/l
0.98
1109
9595
294
1882
1.68
13.45
1.9
1.7
1163.2
1155.0
nmol/l
0.05
222
1460
198
1134
1.84
13.36
10.7
8.6
9.0
8.5
mmol/l
0.33
189
1089
67
255
2.69
12.47
3.1
2.5
17.1
16.7
%
0.30
37
145
153
834
1.91
12.02
1.8
1.7
—
—
—
0
0
352
2420
1.57
11.93
1.8
1.6
79930002.9
36537963.4
pmol/l
0.42
284
2091
70
280
2.56
11.81
3.7
3.7
4.3
4.1
e9/l
0.39
70
280
104
497
2.16
11.73
2.5
1.9
—
—
—
0
0
162
908
1.86
11.68
6.4
4.1
1.2
1.2
mmol/l
0.40
149
797
97
453
2.21
11.58
2.3
1.8
—
—
—
0
0
364
2543
1.55
11.44
3.1
2.2
—
—
—
0
0
70
286
2.51
11.32
4.1
4.0
56.6
56.0
%
0.14
70
286
358
2514
1.53
10.94
1.6
1.5
19.2
20.1
nmol/l
0.57
301
2192
61
241
2.59
10.58
6.1
6.0
357.9
378.0
umol/l
0.43
54
215
235
1509
1.64
10.49
3.1
2.9
5.7
8.1
umol/l
2.39
195
1313
132
717
1.91
10.48
1.4
1.4
—
—
—
0
0
366
2612
1.51
10.31
3.4
2.6
6.4
6.1
e6/l
0.15
330
2307
210
1317
1.68
10.26
4.3
4.2
254.5
240.3
u/l
0.56
193
1258
149
852
1.82
10.08
3.1
2.4
66.6
66.9
g/l
0.15
136
794
206
1293
1.67
10.03
2.3
2.2
334.9
375.4
nmol/l
2.84
186
1208
801
6636
1.38
9.85
3.8
3.1
0.0
0.0
estimate
0.00
193
1278
807
6694
1.38
9.84
3.9
3.2
0.0
0.0
estimate
0.80
189
1262
587
4616
1.41
9.84
2.0
1.8
98.0
95.8
pmol/l
0.53
335
2558
441
3295
1.45
9.80
1.4
1.3
1.8
1.9
u/ml
0.08
114
913
644
5157
1.39
9.67
2.5
2.3
72.0
73.5
nmol/l
0.70
585
4730
651
5230
1.39
9.56
4.0
3.2
—
—
—
0
0
590
4693
1.39
9.09
3.9
3.4
32.8
36.6
u/l
0.49
555
4468
504
3906
1.41
9.04
3.4
3.2
2.4
2.4
mmol/l
0.04
442
3490
795
6639
1.36
9.02
4.9
4.3
0.0
0.0
estimate
0.50
201
1324
1519
14153
1.57
8.98
21.0
13.2
139.4
139.6
mmol/l
2.83
1483
13781
269
1858
1.53
8.73
2.8
2.6
138.6
127.0
ug/g
0.30
199
1495
75
355
2.16
8.72
4.0
4.3
8.5
8.7
kpa
0.29
70
332
70
324
2.21
8.61
3.8
2.5
23.8
24.6
mmol/l
0.68
60
289
1522
14214
1.56
8.60
20.9
13.3
4.0
4.0
mmol/l
2.46
1479
13818
451
3457
1.41
8.54
3.6
3.0
0.4
0.4
e6/l
0.21
350
2588
39
139
2.85
8.30
1.6
1.5
1.4
1.2
promille
0.36
33
107
1372
12602
1.42
7.96
5.1
4.2
1.9
1.9
mu/l
0.39
1259
11715
512
4049
1.37
7.96
4.0
3.3
8.0
8.6
mmol/l
1.60
435
3463
407
3098
1.41
7.95
2.7
2.2
—
—
—
0
0
115
655
1.81
7.90
1.7
1.6
—
—
—
0
0
132
785
1.74
7.84
3.0
2.4
5941.7
3858.9
u/l
0.37
39
316
61
280
2.22
7.69
2.3
2.2
138.4
132.6
g/l
1.12
48
211
216
1472
1.53
7.42
4.3
3.9
31.0
30.9
%
0.05
158
1038
180
1177
1.59
7.42
2.6
2.5
0.2
0.2
g/l
0.17
167
1110
197
1317
1.56
7.38
12.0
8.7
1.5
0.9
mmol/l
1.38
166
1046
1161
10438
1.34
7.30
4.3
3.6
14.6
14.6
pmol/l
0.12
1049
9599
296
2166
1.44
7.13
1.4
1.3
11.2
10.9
u/ml
0.02
113
913
92
509
1.85
6.97
1.3
1.2
0.3
0.9
u/ml
0.65
11
38
438
3442
1.36
6.94
3.0
2.5
3931.5
4259.5
umol/l
0.03
389
3075
83
446
1.90
6.88
2.5
2.2
360.5
440.1
ug/l
0.20
75
416
310
2302
1.42
6.88
1.3
1.3
24.5
28.5
iu/ml
0.35
91
713
195
1323
1.53
6.83
12.0
8.7
5.1
5.1
kpa
0.08
188
1269
195
1323
1.53
6.83
12.0
8.7
11.6
12.6
kpa
2.07
189
1273
183
1225
1.55
6.81
3.7
3.0
1.8
1.8
%
0.32
160
1109
17
40
4.28
6.75
1.7
1.3
8.6
8.6
ug/l
0.03
17
40
1591
15144
1.58
6.74
12.8
9.3
30.0
28.7
u/l
1.13
1542
14700
19
50
3.83
6.54
1.5
1.4
6.4
1.6
%
—
8
13
69
356
1.98
6.46
1.6
1.5
265.9
290.8
ug/g
0.47
37
207
37
147
2.55
6.46
4.1
2.9
0.6
0.9
nmol/l
2.07
32
116
259
1887
1.44
6.36
2.9
2.5
12.5
14.2
umol/l
3.42
236
1765
242
1742
1.45
6.34
2.9
2.4
2.4
2.4
g/l
0.24
224
1623
29
103
2.85
6.27
1.8
1.5
19.3
34.3
%
1.82
22
68
188
1293
1.51
6.18
2.1
1.8
—
—
—
0
0
118
729
1.66
6.13
9.9
8.0
25.3
24.4
mmol/l
1.75
113
679
409
3240
1.34
6.05
1.8
1.6
—
—
—
0
0
1171
10664
1.30
5.99
3.4
3.3
—
—
—
0
0
68
359
1.93
5.98
5.6
4.4
3.9
3.9
mmol/l
0.12
63
338
724
6213
1.28
5.92
4.6
3.9
—
—
—
0
0
23
74
3.14
5.90
2.5
4.1
78.4
160.5
umol/l
—
9
43
50
237
2.14
5.89
1.5
1.4
15.8
18.8
u/l
0.47
41
198
709
6085
1.28
5.74
3.1
2.8
130.3
118.9
ug/l
0.57
644
5712
65
347
1.91
5.55
2.0
1.7
—
—
—
0
0
59
308
1.95
5.39
2.7
3.3
38.1
38.1
umol/l
0.00
51
271
60
318
1.92
5.25
1.4
1.4
—
—
—
0
0
38
169
2.28
5.25
1.2
1.2
—
—
—
0
0
161
1116
1.49
5.11
2.9
2.6
10.4
10.5
g/l
0.07
149
1033
368
2935
1.32
5.11
4.3
3.3
1.0
1.0
kg/l
0.04
52
387
1575
15089
1.46
5.05
20.3
13.5
78.9
76.3
umol/l
1.44
1575
15084
219
1613
1.41
5.04
3.1
2.5
21.5
24.5
%
2.90
182
1404
184
1313
1.45
5.04
2.1
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
347
1.85
4.93
4.5
3.3
0.3
0.3
u/ml
0.12
33
192
46
228
2.05
4.88
2.1
2.5
7.2
5.5
umol/l
0.27
32
172
141
962
1.51
4.85
2.3
2.3
6.6
8.6
ug/l
0.86
124
868
32
137
2.36
4.84
1.6
1.7
57.2
57.2
%
0.00
22
99
252
1917
1.37
4.78
2.4
2.3
30.8
29.7
s
1.90
245
1868
193
1405
1.42
4.75
2.8
2.1
—
—
—
0
0
146
1012
1.48
4.65
3.9
4.5
24.2
16.9
ug/l
0.26
122
824
1397
13184
1.30
4.53
16.1
10.7
88.9
88.4
ml/min/173m2
0.28
1158
10770
437
3630
1.27
4.39
4.0
4.1
15.1
9.5
mg/mmol
0.87
287
2430
1398
13212
1.29
4.36
4.5
3.9
5.9
5.9
mmol/l
1.16
1280
12267
159
1137
1.44
4.33
2.6
1.9
—
—
—
0
0
56
311
1.83
4.31
6.9
7.0
1256.7
581.8
iu/ml
—
7
51
77
470
1.67
4.27
1.8
2.1
1.6
1.5
g/l
0.30
60
409
252
1951
1.34
4.26
3.0
2.9
2.5
2.4
mmol/l
1.75
223
1719
43
220
1.98
4.23
1.6
1.7
—
—
—
0
0
55
306
1.82
4.21
1.5
1.2
—
—
—
0
0
44
230
1.94
4.08
1.2
1.2
—
540.0
—
0
5
195
1461
1.38
4.07
6.0
5.8
—
—
—
0
0
1317
12393
1.26
4.02
6.0
5.0
40.1
39.1
mmol/mol
2.65
1218
11687
27
117
2.33
4.02
1.2
1.3
175773.6
105286.9
e6/l
0.16
20
81
292
2329
1.30
4.00
4.5
3.5
244.0
568.7
ng/l
2.22
206
1638
15
48
3.14
3.93
2.1
1.6
—
—
—
0
0
366
3022
1.27
3.82
2.1
1.8
1.0
1.0
mg/l
0.13
280
2215
23
95
2.44
3.81
1.6
1.3
—
—
—
0
0
51
288
1.79
3.75
4.4
3.3
41.1
33.9
mg/l
0.21
31
221
51
288
1.79
3.75
4.4
3.3
43.0
71.5
mg/l
0.63
31
220
141
1017
1.42
3.69
1.2
1.2
105.5
144.9
iu/ml
0.82
49
392
13
40
3.27
3.62
4.4
7.1
—
—
—
0
0
59
352
1.70
3.61
1.7
1.5
—
16.7
—
0
7
37
191
1.96
3.59
4.3
3.5
1.2
1.2
%
0.02
28
162
70
438
1.62
3.58
2.1
1.9
—
—
—
0
0
151
1111
1.39
3.54
5.5
4.2
2.0
1.9
mmol/l
0.15
131
884
61
372
1.66
3.45
2.4
2.9
—
—
—
0
0
151
1118
1.38
3.41
5.4
4.2
6.0
5.9
kpa
0.85
146
1088
23
101
2.29
3.36
1.3
1.6
—
—
—
0
0
17
65
2.63
3.30
1.2
1.1
159.8
209.9
iu/ml
0.40
17
65
25
115
2.19
3.29
1.2
1.1
—
—
u/ml
—
0
0
40
219
1.85
3.29
2.4
2.0
—
—
—
0
0
60
370
1.64
3.27
2.0
1.9
7.1
7.2
g/l
0.31
45
292
60
370
1.64
3.27
2.0
1.9
—
—
—
0
0
60
370
1.64
3.27
2.0
1.9
3.7
3.8
g/l
0.49
43
277
74
482
1.56
3.23
1.9
1.6
0.0
0.3
iu/ml
1.11
13
81
22
97
2.28
3.20
2.2
1.8
—
—
—
0
0
56
342
1.66
3.18
2.0
1.9
10.0
10.4
g/l
0.31
49
299
47
276
1.72
3.08
1.7
1.4
—
—
—
0
0
17
68
2.51
3.04
2.1
1.8
—
—
—
0
0
48
285
1.70
3.03
1.5
1.7
16851.7
11661.3
e6/l
0.41
33
212
110
789
1.42
3.01
4.3
4.4
92.8
80.6
ng/l
0.58
101
714
24
114
2.12
2.95
1.8
1.4
0.3
0.5
u/ml
0.40
11
49
87
600
1.47
2.94
18.0
11.5
24.5
24.2
mmol/l
0.34
81
574
1656
16196
1.45
2.92
26.9
17.4
4.6
4.6
e12/l
3.89
1612
15786
43
252
1.72
2.86
1.3
1.3
—
—
—
0
0
43
252
1.72
2.86
1.3
1.3
—
—
—
0
0
1656
16202
1.45
2.85
27.3
17.5
137.4
138.9
g/l
3.89
1634
15997
1656
16203
1.45
2.84
27.0
17.4
7.0
6.7
e9/l
7.62
1615
15789
1654
16180
1.44
2.83
27.0
17.4
255.9
250.8
e9/l
2.44
1620
15796
13
47
2.78
2.81
2.0
2.8
25.8
32.3
umol/l
—
8
35
50
307
1.65
2.81
2.0
1.8
—
—
—
0
0
15
59
2.56
2.79
3.2
2.0
—
—
—
0
0
15
59
2.56
2.79
3.2
2.0
—
—
—
0
0
15
59
2.56
2.79
3.1
2.0
—
—
—
0
0
15
59
2.56
2.79
3.2
2.0
—
—
—
0
0
12
42
2.87
2.75
3.1
2.1
10.1
16.5
umol/l
1.99
12
42
53
333
1.61
2.73
1.8
1.5
119.3
118.3
u/ml
0.02
13
62
55
351
1.59
2.67
2.0
2.0
2.8
3.1
g/l
1.03
45
283
158
1227
1.32
2.66
3.2
2.6
28.5
76.4
u/l
0.68
133
1073
30
162
1.87
2.62
1.8
1.5
—
—
—
0
0
51
321
1.61
2.62
2.9
2.0
0.9
0.7
g/l
0.17
44
292
16
68
2.37
2.56
2.1
1.8
—
—
—
0
0
115
858
1.36
2.54
1.5
1.3
—
—
—
0
0
49
309
1.60
2.51
2.4
1.8
—
—
—
0
0
27
143
1.90
2.51
12.5
5.8
6.7
7.3
mmol/l
0.64
21
122
20
95
2.12
2.49
1.0
1.2
1.0
1.0
ratio
—
6
39
29
158
1.85
2.48
1.8
1.5
—
—
—
0
0
29
158
1.85
2.48
1.8
1.5
—
—
—
0
0
12
45
2.68
2.45
2.4
2.3
—
—
—
0
0
12
45
2.68
2.45
2.4
2.3
—
—
—
0
0
29
159
1.84
2.44
1.8
1.5
—
—
—
0
0
29
159
1.84
2.44
1.8
1.5
—
—
—
0
0
25
131
1.92
2.41
2.7
2.2
25.1
20.0
mg/l
—
9
34
66
451
1.48
2.38
1.6
1.6
180.0
353.3
titre
—
5
15
12
46
2.62
2.36
2.5
2.3
—
—
—
0
0
29
161
1.81
2.36
1.8
1.5
—
—
—
0
0
16
71
2.27
2.34
1.2
1.6
0.4
3.2
u/field
—
10
61
250
2088
1.23
2.34
2.6
2.7
0.9
0.9
e6/l
0.00
141
1159
55
364
1.53
2.32
1.3
1.3
250.4
245.8
u/ml
0.04
31
218
122
935
1.33
2.29
5.4
3.6
4.8
4.8
kpa
0.05
117
908
66
456
1.46
2.27
2.4
2.1
1.7
2.0
ug/l
0.15
56
417
8
23
3.49
2.27
1.1
1.2
—
—
—
0
0
21
106
1.99
2.26
2.6
1.7
—
—
—
0
0
21
106
1.99
2.26
2.6
1.7
—
—
—
0
0
21
106
1.99
2.26
2.6
1.7
—
—
—
0
0
27
149
1.82
2.25
2.2
2.0
—
—
—
0
0
23
121
1.91
2.21
3.2
3.3
60.6
54.6
%
0.36
13
87
10
36
2.79
2.20
3.6
2.8
—
—
—
0
0
10
36
2.79
2.20
3.6
2.8
—
—
—
0
0
108
819
1.34
2.18
2.7
3.4
4.4
4.6
pmol/l
1.31
90
741
58
395
1.48
2.16
1.3
1.1
—
—
—
0
0
44
282
1.57
2.15
1.2
1.2
—
—
—
0
0
25
138
1.82
2.09
2.2
2.1
33.3
33.0
pg
0.11
25
138
56
382
1.48
2.08
1.3
1.3
—
—
—
0
0
17
82
2.08
2.07
2.1
1.7
—
—
—
0
0
111
853
1.32
2.07
4.0
2.8
166.8
153.4
ng/l
0.14
99
771
58
399
1.47
2.07
1.3
1.2
—
—
—
0
0
19
96
1.99
2.05
1.0
1.1
—
—
—
0
0
8
26
3.09
2.01
1.5
1.3
—
—
—
0
0
1380
13316
1.17
2.01
4.0
3.6
1.4
1.3
mmol/l
3.99
1280
12502
24
133
1.82
2.00
11.4
2.0
—
—
—
0
0
38
240
1.60
1.99
1.5
1.6
—
—
—
0
0
108
832
1.32
1.99
1.1
1.0
—
—
—
0
0
7
21
3.34
1.96
1.0
1.1
—
—
—
0
0
5
11
4.55
1.94
3.0
2.4
1.8
4.5
mg/l
—
5
11
68
491
1.40
1.89
1.6
1.8
—
—
—
0
0
7
23
3.05
1.80
3.1
2.4
1.2
1.2
mmol/l
—
7
23
20
109
1.84
1.77
2.8
2.3
9.9
11.9
%
—
9
58
63
455
1.40
1.77
1.6
1.4
—
—
—
0
0
19
102
1.87
1.76
2.3
2.5
—
—
—
0
0
6
18
3.34
1.74
1.2
1.1
—
—
—
0
0
127
1020
1.26
1.73
2.2
2.4
67.9
72.8
ml/min/173m2
0.61
56
372
5
13
3.85
1.71
2.0
1.7
210.0
114.2
ng/l
—
5
13
229
1962
1.19
1.69
2.8
2.9
2.1
2.0
e6/l
0.09
120
1046
30
188
1.61
1.66
2.1
1.8
—
—
—
0
0
25
150
1.68
1.63
1.9
1.8
—
—
—
0
0
59
429
1.39
1.62
7.8
4.8
1.7
1.4
mg/l
1.15
53
400
18
98
1.85
1.61
2.9
2.3
—
—
—
0
0
6
20
3.01
1.58
1.3
1.8
—
—
—
0
0
14
71
1.98
1.54
1.1
1.1
1646.4
1455.9
miu/ml
0.21
14
71
8
33
2.43
1.53
1.3
1.2
—
—
—
0
0
0
42
0.00
1.52
0.0
1.0
—
33.8
—
0
42
6
21
2.86
1.50
6.3
2.5
—
—
—
0
0
9
38
2.38
1.45
1.1
1.1
—
—
—
0
0
39
269
1.46
1.44
1.3
1.3
1.0
4.7
u/ml
—
5
23
13
66
1.98
1.43
1.5
1.3
113.9
460.3
u/l
1.45
13
61
9
40
2.26
1.40
1.1
1.1
—
—
—
0
0
48
347
1.39
1.39
1.4
1.2
4.6
11.6
u/ml
—
8
62
74
574
1.30
1.37
1.8
1.5
8.1
7.8
u/l
0.10
64
465
9
41
2.20
1.37
1.1
1.1
—
—
—
0
0
6
23
2.61
1.36
1.3
1.2
—
—
—
0
0
5
17
2.95
1.36
1.4
1.1
—
—
—
0
0
35
241
1.46
1.33
1.1
1.1
—
—
—
0
0
47
342
1.38
1.33
1.4
1.2
6.3
2.7
u/ml
—
6
39
44
319
1.39
1.28
2.2
2.4
327.8
142.5
ug/min
0.64
28
199
69
538
1.29
1.25
1.5
1.4
—
—
—
0
0
6
25
2.40
1.24
1.0
1.4
—
—
—
0
0
23
147
1.57
1.23
1.1
1.5
340.9
340.5
pmol/l
0.00
18
120
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
16
93
1.73
1.21
1.5
1.9
0.6
1.7
u/field
—
8
53
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
13
71
1.84
1.19
1.7
1.6
132.2
132.7
%
0.01
13
66
28
405
0.69
1.18
1.5
1.5
—
—
—
0
0
36
256
1.41
1.18
1.1
1.1
19.2
1943.6
iu/ml
0.52
11
67
12
65
1.85
1.13
1.5
1.4
—
—
—
0
0
12
65
1.85
1.13
6.7
3.5
—
—
—
0
0
12
65
1.85
1.13
1.5
1.4
—
—
—
0
0
8
40
2.00
1.12
3.3
1.8
—
—
—
0
0
8
40
2.00
1.12
1.1
1.1
—
—
—
0
0
1434
14029
1.13
1.11
4.7
4.3
2.8
2.8
mmol/l
1.81
1330
13155
18
112
1.61
1.09
2.7
1.9
—
—
—
0
0
8
41
1.96
1.09
1.1
1.1
—
—
—
0
0
59
461
1.29
1.08
5.6
6.5
2.0
1.7
%
0.48
54
428
1412
13807
1.12
1.08
4.4
4.0
1.4
1.4
mmol/l
2.54
1317
12984
1419
13882
1.12
1.07
4.4
4.0
4.6
4.7
mmol/l
1.86
1325
13108
11
192
0.57
1.06
2.0
1.4
29.4
62.4
pmol/l
—
5
66
7
34
2.06
1.03
7.1
5.9
—
—
—
0
0
20
130
1.54
1.02
1.1
1.7
—
—
—
0
0
78
637
1.23
1.01
5.8
4.7
24.4
24.1
mmol/l
0.44
67
582
9
49
1.84
0.98
1.3
1.2
—
—
—
0
0
174
1534
1.15
0.97
2.6
2.3
12.3
13.4
nmol/l
1.08
147
1396
20
133
1.51
0.94
2.1
1.9
—
—
—
0
0
44
338
1.31
0.94
1.9
1.7
—
—
—
0
0
9
52
1.73
0.92
1.8
2.4
—
—
—
0
0
19
126
1.51
0.91
4.1
2.6
729.0
725.0
e6/l
—
9
53
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
8
44
1.82
0.86
1.1
1.2
—
—
—
0
0
33
248
1.34
0.84
1.2
1.1
—
—
—
0
0
36
467
0.77
0.83
1.5
1.4
—
—
—
0
0
36
466
0.77
0.82
1.5
1.4
—
—
—
0
0
12
73
1.65
0.81
1.1
1.8
—
—
—
0
0
36
465
0.77
0.81
1.5
1.4
—
—
—
0
0
36
464
0.77
0.80
1.5
1.4
—
—
—
0
0
71
594
1.20
0.77
1.2
1.3
200.9
232.0
miu/ml
0.35
27
289
31
235
1.32
0.76
2.0
1.7
—
—
—
0
0
282
3050
0.91
0.76
2.8
2.7
0.6
0.7
ug/l
0.68
171
1814
41
514
0.79
0.75
1.4
1.5
—
—
—
0
0
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
9
54
1.67
0.74
3.9
2.7
—
—
—
0
0
28
210
1.34
0.74
2.1
1.2
32.0
31.6
u/l
0.01
23
179
9
56
1.61
0.72
1.2
1.2
—
—
—
0
0
24
177
1.36
0.70
1.9
1.6
—
—
—
0
0
154
1712
0.89
0.70
1.5
1.7
—
—
—
0
0
20
143
1.40
0.70
1.1
1.1
—
—
—
0
0
51
618
0.82
0.69
1.5
1.4
—
—
—
0
0
9
58
1.55
0.69
1.7
1.4
—
—
—
0
0
9
58
1.55
0.69
1.7
1.4
—
—
—
0
0
71
602
1.19
0.69
1.5
2.1
40.4
39.5
u/l
0.17
65
543
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
12
78
1.54
0.65
1.6
1.3
11.3
8.1
u/l
0.20
12
62
17
120
1.42
0.64
1.1
1.1
—
—
—
0
0
34
270
1.26
0.62
2.8
3.3
29.0
26.1
mg/l
0.22
23
164
19
139
1.37
0.60
1.1
1.1
—
—
—
0
0
30
236
1.28
0.60
1.2
1.3
—
—
—
0
0
50
418
1.20
0.59
4.3
3.8
5817.7
3447.2
u/ml
0.19
41
357
0
23
0.00
0.58
0.0
1.0
—
0.0
—
0
15
0
23
0.00
0.58
0.0
1.0
—
0.0
—
0
14
0
23
0.00
0.58
0.0
1.0
—
0.0
—
0
15
32
255
1.26
0.58
1.3
1.2
2.9
3.7
u/ml
0.24
16
91
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
1243
12205
1.06
0.56
21.6
14.6
13.7
13.5
%
4.06
1218
11949
83
943
0.87
0.56
1.5
1.5
—
—
—
0
0
9
60
1.50
0.54
1.3
1.2
—
—
—
0
0
17
125
1.36
0.53
1.2
1.1
—
—
—
0
0
536
5144
1.06
0.53
4.2
4.0
1.8
2.0
ug/l
0.59
471
4700
21
271
0.77
0.52
1.3
1.1
—
10.3
—
0
23
12
83
1.45
0.51
2.2
2.2
—
—
—
0
0
16
214
0.75
0.51
4.4
2.9
1.6
1.5
mmol/l
0.39
16
208
23
179
1.29
0.51
1.2
1.1
—
—
—
0
0
26
206
1.27
0.51
1.9
1.5
—
—
—
0
0
7
45
1.56
0.49
1.0
1.0
—
—
—
0
0
30
244
1.23
0.48
2.1
1.8
—
—
—
0
0
20
156
1.29
0.45
1.3
1.3
—
—
—
0
0
5
32
1.56
0.42
1.8
1.5
—
—
—
0
0
8
58
1.38
0.41
1.1
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
14
105
1.34
0.41
1.2
1.6
0.9
1.0
g/l
0.68
14
105
23
186
1.24
0.40
2.3
1.7
—
—
—
0
0
36
306
1.18
0.39
1.5
2.2
1.1
0.8
nmol/l
1.64
28
265
0
19
0.00
0.39
0.0
1.0
—
1.3
—
0
12
29
242
1.20
0.39
1.3
1.4
51.4
118.0
pmol/l
0.87
29
235
5
37
1.35
0.37
1.6
1.6
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
44
384
1.15
0.36
1.2
1.1
4.0
2.3
u/ml
0.24
26
154
21
171
1.23
0.35
1.2
1.1
—
—
—
0
0
13
99
1.32
0.35
1.0
1.0
—
—
—
0
0
13
100
1.30
0.33
2.2
2.0
—
—
—
0
0
21
173
1.22
0.33
1.2
1.1
95.8
97.0
%
0.08
21
164
27
229
1.18
0.32
1.1
1.1
—
—
—
0
0
78
714
1.10
0.31
1.9
1.6
325.7
288.9
mu/l
0.62
69
651
58
523
1.11
0.31
1.9
1.9
—
—
—
0
0
7
55
1.27
0.30
1.1
1.0
—
—
—
0
0
29
251
1.16
0.28
1.3
1.2
8.7
5.6
u/ml
0.17
12
110
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
11
86
1.28
0.26
1.3
1.1
—
—
—
0
0
1381
13698
1.04
0.26
17.7
12.5
40.6
41.0
%
0.90
1010
10836
9
73
1.23
0.25
1.6
1.3
—
—
—
0
0
46
416
1.11
0.25
1.3
1.1
—
—
—
0
0
11
137
0.80
0.24
1.0
1.1
—
—
—
0
0
362
3517
1.04
0.24
1.7
1.7
1.6
1.5
mmol/l
0.92
294
3008
28
246
1.14
0.23
1.0
1.0
0.4
0.3
u/ml
—
9
61
5
38
1.32
0.23
1.2
1.2
105.8
104.8
%
—
5
33
12
97
1.24
0.23
1.4
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
1.4
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
9
111
0.81
0.20
1.4
1.1
—
—
—
0
0
15
127
1.18
0.19
1.1
1.2
81.8
56.7
u/l
—
10
89
6
52
1.15
0.19
1.2
1.2
0.3
0.3
g/l
—
6
46
18
156
1.16
0.18
1.2
1.1
—
—
—
0
0
61
651
0.93
0.18
1.5
1.8
4.0
3.6
mg/l
0.18
47
448
11
91
1.21
0.17
1.7
1.7
—
—
—
0
0
7
63
1.11
0.17
2.4
2.1
191.0
201.0
u/l
—
7
63
8
72
1.11
0.16
1.8
3.5
1607.3
999.9
u/ml
—
8
72
47
438
1.08
0.15
1.6
1.3
—
—
—
0
0
13
111
1.17
0.15
1.2
1.2
—
—
—
0
0
401
4086
0.98
0.15
3.9
3.6
22.5
21.0
%
0.86
155
1717
39
421
0.92
0.15
1.8
1.7
—
—
—
0
0
38
351
1.08
0.15
1.9
1.9
287.2
5.2
iu/l
0.47
11
127
9
80
1.13
0.15
1.4
1.3
—
—
—
0
0
13
112
1.16
0.14
1.2
1.2
—
—
—
0
0
22
242
0.91
0.13
1.0
1.0
1.7
2.1
u/ml
—
5
120
9
108
0.83
0.13
1.4
1.1
—
—
—
0
0
9
108
0.83
0.13
1.4
1.1
—
—
—
0
0
9
110
0.82
0.13
1.4
1.1
—
—
—
0
0
9
110
0.82
0.13
1.4
1.1
—
—
—
0
0
27
249
1.09
0.12
1.6
1.6
0.3
0.3
nmol/l
0.24
19
211
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
95
1.16
0.11
1.3
1.1
—
—
—
0
0
12
136
0.88
0.11
1.6
1.7
8.0
7.7
mmol/l
—
7
83
75
721
1.04
0.10
1.5
1.4
22.6
22.7
iu/l
0.02
67
592
16
144
1.11
0.10
1.4
1.5
—
—
—
0
0
35
371
0.94
0.09
1.5
1.5
—
—
—
0
0
20
184
1.09
0.09
1.3
1.3
—
—
—
0
0
66
685
0.96
0.09
1.7
1.9
—
—
—
0
0
6
56
1.07
0.08
2.5
1.2
—
—
—
0
0
10
113
0.88
0.08
1.2
1.6
—
—
—
0
0
6
71
0.84
0.07
3.8
3.0
17.4
57.5
u/ml
—
6
71
23
215
1.07
0.07
2.2
4.3
774.3
212.3
u/ml
0.33
17
203
8
94
0.85
0.06
1.3
1.2
—
—
—
0
0
17
183
0.93
0.06
1.1
1.1
—
—
—
0
0
12
109
1.10
0.06
2.8
4.0
—
—
—
0
0
20
212
0.94
0.05
1.4
1.2
—
—
—
0
0
30
287
1.05
0.05
1.1
1.1
3.8
4.3
u/ml
0.06
14
114
197
1992
0.99
0.04
1.6
1.5
—
—
—
0
0
20
210
0.95
0.03
1.2
1.4
6.6
7.4
mmol/l
0.57
13
152
12
112
1.07
0.03
1.3
1.7
12.5
12.3
umol/l
0.05
12
106
27
262
1.03
0.02
1.0
1.1
7.0
4.7
u/ml
0.14
13
114
24
233
1.03
0.01
1.1
1.1
—
—
—
0
0
11
111
0.99
0.00
1.3
1.7
—
—
—
0
0
13
125
1.04
0.00
1.7
1.2
—
—
—
0
0
46
460
1.00
0.00
1.5
1.5
—
—
—
0
0
23
230
1.00
0.00
1.7
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
2.9
—
0
9
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
5.0
—
420.4
—
0
9
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
7
69
1.01
0.00
1.9
2.7
30.2
134.6
ug/l
—
7
60
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
6.1
—
—
—
0
0
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
7
77
0.91
0.00
2.4
2.8
53.9
52.0
umol/l
—
7
65
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_SCABIES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SCABIES | 1.897 [1.55, 2.32] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.188 |
During the follow-up period (1.1.1998 — 31.12.2019), 457 out of 3923 females with AB1_SCABIES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SCABIES | 2.234 [1.83, 2.72] | < 0.001 |
| Birth year | 0.979 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 631 out of 5243 males with AB1_SCABIES died.
Mortality risk
Mortality risk for people of age
years, who have AB1_SCABIES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.172% | 0.316% |
| 5 | 1.17% | 1.926% |
| 10 | 2.837% | 5.155% |
| 15 | 5.23% | 9.718% |
| 20 | 9.268% | 15.581% |
Relationships between endpoints
↥Index endpoint: AB1_SCABIES – Scabies
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data